Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase (Q28204166)

Europe PubMed Central

PubMed ID

14502282

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502282

12 March 2024

author name string

Catherine Uyttenhove

1

0 references

Luc Pilotte

2

0 references

Ivan Théate

3

0 references

Vincent Stroobant

4

0 references

Didier Colau

5

0 references

Nicolas Parmentier

6

0 references

Thierry Boon

7

0 references

Benoît J. Van den Eynde

8

1 reference

Europe PubMed Central

PubMed ID

14502282

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502282

12 March 2024

language of work or name

English

0 references

publication date

October 2003

0 references

21 September 2003

1 reference

Europe PubMed Central

PubMed ID

14502282

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502282

full work available at URL

12 March 2024

http://www.nature.com/articles/nm934.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/NM934

http://www.nature.com/articles/nm934

12 March 2024

1 reference

https://api.crossref.org/works/10.1038/NM934

12 March 2024

0 references

9

0 references

page(s)

1269-74

0 references

issue

10

0 references

cites work

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

1 reference

7 January 2021

Prevention of allogeneic fetal rejection by tryptophan catabolism

1 reference

7 January 2021

Inhibition of T cell proliferation by macrophage tryptophan catabolism

1 reference

7 January 2021

Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation

1 reference

7 January 2021

Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation

1 reference

7 January 2021

T cell proliferation is blocked by indoleamine 2,3-dioxygenase.

1 reference

7 January 2021

Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells

1 reference

7 January 2021

Cloning and expression of a cDNA encoding mouse indoleamine 2,3-dioxygenase

1 reference

7 January 2021

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

1 reference

7 January 2021

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

1 reference

7 January 2021

CTLA-4-Ig regulates tryptophan catabolism in vivo.

1 reference

7 January 2021

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

1 reference

7 January 2021

The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection

1 reference

7 January 2021

Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors

1 reference

7 January 2021

1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase

1 reference

7 January 2021

Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection.

1 reference

7 January 2021

Characterisation of L-tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles

1 reference

7 January 2021

Ancient adaptation of the active site of tryptophanyl-tRNA synthetase for tryptophan binding.

1 reference

7 January 2021

Identification and characterization of human mitochondrial tryptophanyl-tRNA synthetase

1 reference

7 January 2021

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

1 reference

7 January 2021

T cell apoptosis by tryptophan catabolism

1 reference

7 January 2021

T cell defined tumor antigens

1 reference

7 January 2021

1 reference

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

7 January 2021

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

7 January 2021

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

7 January 2021

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

1 reference

7 January 2021

Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide

1 reference

7 January 2021

Selection of highly transfectable variant from mouse mastocytoma P815.

1 reference

7 January 2021

TNF-mediated toxicity after massive induction of specific CD8+ T cells following immunization of mice with a tumor-specific peptide

1 reference

7 January 2021

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

1 reference

7 January 2021